Department of Neurochemistry, Institute of Physiology Czech Academy of Sciences, 142 20 Prague, Czech Republic.
Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA.
Int J Mol Sci. 2021 Feb 16;22(4):1953. doi: 10.3390/ijms22041953.
G-protein coupled receptors (GPCRs) are membrane proteins that convey extracellular signals to the cellular milieu. They represent a target for more than 30% of currently marketed drugs. Here we review the effects of membrane cholesterol on the function of GPCRs of Class A. We review both the specific effects of cholesterol mediated via its direct high-affinity binding to the receptor and non-specific effects mediated by cholesterol-induced changes in the properties of the membrane. Cholesterol binds to many GPCRs at both canonical and non-canonical binding sites. It allosterically affects ligand binding to and activation of GPCRs. Additionally, it changes the oligomerization state of GPCRs. In this review, we consider a perspective of the potential for the development of new therapies that are targeted at manipulating the level of membrane cholesterol or modulating cholesterol binding sites on to GPCRs.
G 蛋白偶联受体(GPCRs)是将细胞外信号转导至细胞环境的膜蛋白。它们是目前市场上超过 30%的药物的靶点。在这里,我们回顾了膜胆固醇对 A 类 GPCR 功能的影响。我们既回顾了胆固醇通过其与受体的直接高亲和力结合介导的特定作用,也回顾了胆固醇诱导的膜性质变化介导的非特异性作用。胆固醇在经典和非经典结合位点与许多 GPCR 结合。它变构影响配体与 GPCR 的结合和激活。此外,它改变了 GPCR 的寡聚状态。在这篇综述中,我们考虑了一种潜在的新疗法的发展前景,该疗法旨在操纵膜胆固醇的水平或调节 GPCR 上的胆固醇结合位点。